Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Regulatory News (VAL)

Share Price Information for ValiRx (VAL)

Share Price is delayed by 15 minutes
Get Live Data
0.165    -0.01 (-5.71%)
Bid:
0.16
Ask:
0.17
Spread: 0.01 (6.25%)
Market Cap: £2.18m
VAL Live PriceLast checked at - London Stock Exchange

Intraday ValiRx Share Chart

Directorate Change

12 May 2006 14:49

Azure Holdings PLC12 May 2006 Azure Holdings plc (the "Company") Board changes The Company announces the appointment of Barry Gold and Gerald Desler asdirectors of the Company, and the resignation of the existing directors,Nicholas Greenstone and Ronald Stirling, with immediate affect. Barry Gold, age 58, is a solicitor with experience of fully listed andAIM-quoted companies. Mr Gold is currently the chairman and joint managingdirector of Premier Management Holdings plc, an AIM-quoted football agency. Mr Gold's current directorships are as follows: BG Consultancy Services Limited, Matisse Holdings plc, Nemesis Marketing Groupplc, Premier Management Holdings plc, Premier Management Recruitment Limited,Premier Management Snooker Limited, Venture Six plc. In the past five years Mr Gold has been a director of the following companies: Aimwright Limited, Apollo Metals plc, Avent Limited, Avent Enterprises Limited,Bracken Partners Limited, Bracken Partners Group Limited, Cannon Avent Groupplc, Cannon Avent Limited, Capitol Group plc, Dudley Jenkins Group plc, EssexFurniture plc (1), Hopeflow Properties Limited, Kingstonian Football ClubLimited, London Asia Capital plc, Moving Homes Limited, Non-League Media plc(2), Pure Holdings Limited, Southern Homes & Properties Limited, TimeframedLimited (3), Underwriting and Subscription plc, Yorkplan Limited. (1) Mr Gold was a non-executive director at the time of or within the 12 monthspreceding the administrative receivership of Essex Furniture plc which occurredin October 1998. At the time the administration order was made for EssexFurniture plc in October 1998, the estimated deficiency with regards tocreditors was £17,044,308. The majority of this related to estimated rents duein respect of the remaining terms of leases, all but two of which by December1999 had either been assigned or returned to the landlords; customers' deposits,where the goods have now been substantially delivered; and a VAT repayment of£2.35 million. (2) Mr Gold was also a non-executive director at the time of or within the 12months preceding the administrative receivership of Non-League Media plc, whichoccurred in June 2002. At the time the administration order was granted, theestimated deficiency with regards to creditors was £116,999. (3) Mr Gold was also a non-executive director at the time of or within the 12months preceding the insolvent liquidation of Timeframed Limited, which occurredin November 2001. At the time of the appointment of the liquidator to TimeframedLimited, the deficiency as regards to creditors was £8,361,386, of which£4,500,000 was in respect of loan stock holders; £3,000,000 was owed to thefounder; £41,512 to preferential creditors; and £423,586 to unsecured creditors. Mr Gold was a non-executive director at the time of or within the 12 monthspreceding the administrative receivership of Clearmark Group plc, which occurredin August 1991. The receivers ceased to act for Clearmark Group plc in 1998,which was subsequently dissolved by notice in the London Gazette, dated 20 April1999. Gerald Desler, age 60, is a chartered accountant, who qualified in 1968 withStanley A Spofforth & Co., becoming a partner in 1970 and a senior partner in1985. Mr Desler is currently the finance director of Premier Management Holdingsplc. Mr Desler's current directorships are as follows: 140 High Street Management Limited, Andrew Manning Limited, Andrew MillsConsultancy Limited, Aralbest Limited, Babble.net Group plc, BG ConsultancyServices Limited, C&R Civil Enforcement Services Limited (4), Click 4 SupportLimited, Desler Consulting Limited, Managed Services Solutions Limited, MSCAgency Limited, Premier Management Football Limited, Premier Management Holdingsplc, Premier Management Recruitment Limited, Southern Homes & PropertiesLimited, Sports Player Management Limited (5), Student Link plc, Tangent MediaGroup Limited, Venture Six plc, In the past five year's Mr Desler has been a director of the following: Global Screen Ad Services Limited, Global Screen Ad Systems Limited, KingstonianFootball Club Limited, Milefarm Limited, Noviceguru Limited, Resday Limited,Signactual Limited, The Online Shop Web Fulfilment Limited, Theonlineshop.co.ukLimited, Theonlineshop.TV Limited, Yorkplan Limited (4) On 9 August 2001, Mr Desler was appointed a director of C&R CivilEnforcement Services Limited. A liquidator was appointed on 18 October 2004. Theliquidation is ongoing. (5) Mr Desler is a director of Sports Player Management Limited which went intoliquidation in April 2006. The liquidation is ongoing. Mr Desler was a director of Grovefair plc, which went into voluntaryreceivership in March 1997. He had resigned as a director on 31 March 1996.Following his resignation as a director of Grovefair plc, it undertook areorganisation whereby it was divided into two separately owned entities. WhileGrovefair plc went into voluntary receivership, the other entity did not. There are no further disclosures required under Schedule Two (g) of the AIMrules. For further information please contact: Barry Gold, Azure Holdings plc Tel: 07768 948 928David Youngman, WH Ireland Limited Tel: 0161 832 2174 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
26th May 20168:00 amRNSPosting of Annual Report & Notice of AGM
19th May 201611:00 amRNSFinal Results
19th May 20167:00 amRNSValiSeek Clinical Development Update
18th May 20164:45 pmRNSConversion of Loan Note, issue of warrant & equity
29th Apr 20167:00 amRNSNotification of US Patent Grant for VAL401
26th Apr 201612:07 pmRNSIssue of Equity
22nd Apr 201610:01 amRNSValiRx to exhibit at the UK Investor Show
19th Apr 20163:32 pmRNSIssue of Equity - conversion of loan note
18th Apr 20165:00 pmRNSIssue of Equity - conversion of loan note
1st Apr 20163:10 pmRNSConversion of Loan Note, issue of warrant & equity
31st Mar 20167:00 amRNSValiRx to exhibit and present at the AACR
21st Mar 20167:00 amRNSConvertible Loan Facility of up to £4.0 million
17th Mar 20167:00 amRNSValiRx engages US investor relations firm
17th Feb 20161:00 pmRNSPlacing to raise £0.5 million
16th Feb 20167:00 amRNSVAL201 Clinical Trial Update
9th Feb 20167:00 amRNSQuarterly Update on Clinical Progress
11th Dec 20159:30 amRNSValiRx to present at Shares Investor Meeting
19th Nov 201510:45 amRNSClinical Phase Development Update
5th Nov 20157:00 amRNSValiRx establishes US office in Boston, MA
27th Oct 20157:00 amRNSCollaboration Agreement
1st Oct 20157:00 amRNSNew Japanese Patent Grant
17th Sep 201512:15 pmRNSHalf Yearly Report
16th Sep 20157:00 amRNSSubscription and Equity Swap
6th Aug 20157:00 amRNSCollaboration and Research Studentship Agreement
21st Jul 20157:00 amRNSVAL201 Clinical Trial Update
16th Jul 20157:00 amRNSValiSeek Clinical Development Update
29th Jun 20157:00 amRNSGrant of options
25th Jun 20157:00 amRNSUPDATE on VAL201 Clinical Trial
3rd Jun 20157:00 amRNSChange of Adviser
27th May 201511:22 amRNSStmnt re Share Price Movement
15th May 20152:45 pmRNSResult of AGM and Capital Reorganisation
14th May 20153:50 pmRNSNotification of US Patent Grant Allowance reVAL401
14th May 20157:00 amRNSValiSeek Development Update
7th May 20157:00 amRNSRe Contract
30th Apr 20157:00 amRNSValiRX to attend 2015 BIO International Convention
22nd Apr 20157:00 amRNSNotice of AGM and Proposed Capital Reorganisation
16th Apr 20157:00 amRNSFinal Results
17th Mar 20157:00 amRNSIssue of equity to Cancer Research Technology Ltd
6th Mar 20157:00 amRNSPlacing to raise GBP800,000
26th Feb 20157:00 amRNSNew Endometriosis Patent Grant
24th Feb 20157:00 amRNSSuccessful 1st Results from VAL201 Clinical Trial
11th Feb 20157:00 amRNSNew European Patent Grant
5th Feb 20157:00 amRNSAcquisition
15th Jan 20157:00 amRNSClinical Trial and Development Update
18th Dec 20147:00 amRNSIssue of Equity
4th Dec 20147:00 amRNSValiSeek Scientific Update
26th Nov 20147:00 amRNSRe: Progress with Trial Recruitment and Testing
13th Nov 20147:00 amRNSCollaboration Agreement
7th Nov 201410:23 amRNSHolding(s) in Company
3rd Nov 201411:00 amRNSApproved Clinical Trial Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.